Jack Ball serves as Executive at Cytek Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Jack Ball has executed 5 insider transactions totaling $286.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 29, 2022 involved exercising options for 10,666 shares valued at $4.3K.
Jack Ball currently holds 13,666 shares of Cytek Biosciences, Inc. (CTKB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jack Ball has been a net seller of CTKB stock. They have purchased $51.0K and sold $235.0K worth of shares.
Jack Ball's most recent insider trade was on Nov 29, 2022, when they sold 10,666 shares at $0.40 per share.
Get notified when new Form 4 filings are submitted
| 13,333 |
| $0.92 |
| Discretionary |
| Nov 14, 2022 | CTKB | $235.0K | Sale | 16,000 | $14.69 | Discretionary |
| Nov 14, 2022 | CTKB | $6.4K | Option Exercise | 16,000 | $0.40 | Discretionary |
| Jul 22, 2021 | CTKB | $51.0K | Purchase | 3,000 | $17.00 | Discretionary |